Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001299597 | SCV001488696 | uncertain significance | Fanconi anemia | 2021-09-25 | criteria provided, single submitter | clinical testing | This sequence change replaces arginine with tryptophan at codon 19 of the FANCA protein (p.Arg19Trp). The arginine residue is weakly conserved and there is a moderate physicochemical difference between arginine and tryptophan. The frequency data for this variant in the population databases is considered unreliable, as metrics indicate insufficient coverage at this position in the ExAC database. This variant has not been reported in the literature in individuals affected with FANCA-related conditions. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Institute for Clinical Genetics, |
RCV003238338 | SCV002010164 | uncertain significance | not provided | 2021-11-03 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV001760347 | SCV002784831 | uncertain significance | Fanconi anemia complementation group A | 2022-03-25 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001299597 | SCV002093155 | uncertain significance | Fanconi anemia | 2020-03-20 | no assertion criteria provided | clinical testing |